Selection of patients with hepatocellular carcinoma before liver transplantation:need to combine alpha-fetoprotein with morphology?

被引：2
作者：
Christian Toso [1 ]
Gilles Mentha [1 ]
Pietro Majno [1 ]
机构：
[1] Abdominal and Transplant Surgery,University Hospitals of Geneva
来源：
Hepatobiliary&PancreaticDiseasesInternational | 2010年 / 9卷 / 05期
关键词：
HCC; AFP; Selection of patients with hepatocellular carcinoma before liver transplantation;
D O I：
暂无
中图分类号：
R735.7 [肝肿瘤];
学科分类号：
100214 ;
摘要：
Liver transplantation is the best treatment for selected patients with unresectable hepatocellular carcinoma (HCC). While candidate selection has been historically based on the restrictive Milan
引用
收藏
页码：460 / 461
页数：2
相关论文
共 50 条
  • [41] Evaluation of Total Tumor Volume and Pretransplantation α-Fetoprotein Level as Selection Criteria for Liver Transplantation in Patients With Hepatocellular Cancer
    Grat, M.
    Kornasiewicz, O.
    Holowko, W.
    Lewandowski, Z.
    Zieniewicz, K.
    Paczek, L.
    Krawczyk, M.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (05) : 1899 - 1903
  • [42] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Cheng Xu
    Zhehui Yan
    Liang Zhou
    Yuming Wang
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1417 - 1424
  • [43] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Xu, Cheng
    Yan, Zhehui
    Zhou, Liang
    Wang, Yuming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1417 - 1424
  • [44] Glypican-3 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
    Fu, Weiyu
    Lu, Hongyu
    Li, Li
    Wu, Kefeng
    Li, Yanping
    Liu, Yi
    Hu, Jianli
    BIOCELL, 2015, 39 (2-3) : 25 - 31
  • [45] Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma
    Abdel-Aziz, Mohamed M.
    Elshal, Mohamed F.
    Abass, Aymn T.
    El-Kafrawy, Sherif
    Ezzat, Sameera
    Abdel-Wahab, Mohamed
    CLINICAL LABORATORY, 2016, 62 (06) : 1121 - 1129
  • [46] Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
    Caviglia, Gian Paolo
    Ciruolo, Michela
    Abate, Maria Lorena
    Carucci, Patrizia
    Rolle, Emanuela
    Rosso, Chiara
    Olivero, Antonella
    Troshina, Giulia
    Risso, Alessandra
    Nicolosi, Aurora
    Ribaldone, Davide Giuseppe
    Armandi, Angelo
    Tandoi, Francesco
    Saracco, Giorgio Maria
    Bugianesi, Elisabetta
    Ciancio, Alessia
    Gaia, Silvia
    CANCERS, 2020, 12 (11) : 1 - 14
  • [47] Rapid and portable detection of hepatocellular carcinoma marker alpha-fetoprotein using a droplet evaporation-based biosensor
    Jia, Ying
    Zhao, Hui
    Huang, Shitang
    Yin, Fangchao
    Wang, Weiwei
    Hu, Qiongzheng
    Wang, Yunshan
    Feng, Bin
    TALANTA, 2025, 294
  • [48] Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma
    Tsilimigras, Diamantis I.
    Hyer, J. Madison
    Diaz, Adrian
    Bagante, Fabio
    Ratti, Francesca
    Marques, Hugo P.
    Soubrane, Olivier
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Workneh, Aklile
    Guglielmi, Alfredo
    Hugh, Tom
    Aldrighetti, Luca
    Endo, Itaru
    Pawlik, Timothy M.
    CANCERS, 2021, 13 (04) : 1 - 12
  • [49] The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria
    Toso, Christian
    Kneteman, Norman M.
    Shapiro, A. M. James
    Bigam, David L.
    TRANSPLANT INTERNATIONAL, 2009, 22 (09) : 869 - 875
  • [50] Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective
    Moeckli, Beat
    Majno, Pietro
    Orci, Lorenzo A.
    Peloso, Andrea
    Toso, Christian
    SEMINARS IN LIVER DISEASE, 2021, 41 (02) : 172 - 181
12345